Dediabetes Logo
Centro de evidencia
Descubre que funciona
Evidence Explorer
Busca en el grafo completo de evidencia
Investigacion reciente
Estudios mas recientes
Que cambio
Inteligencia semanal
Configuracion
Entrar / Unirse
Resumen de Investigación
Analyzed using Evidence Intelligence™

Mobile Health App Shows Noninferiority for Diabetes Management

Desarrollado con el marco Evidence Intelligence™ de Dediabetes

Última actualización 8 de julio de 2026

Key finding

The uMARS analysis showed a high rating (≥4 out of 5) of acT1ve by 80% of participants for both functionality and information.

This study evaluated the noninferiority of the acT1ve mobile health app for managing exercise in young people with Type 1 diabetes, finding similar rates of hypoglycemia before and during app use.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study evaluated the noninferiority of the acT1ve mobile health app for managing exercise in young people with Type 1 diabetes, finding similar rates of hypoglycemia before and during app use.

Clinical relevance

This study is significant as it suggests that mobile health apps like acT1ve can be safely integrated into the diabetes management routine of young individuals without increasing the risk of hypoglycemia. This could encourage more young people to engage in physical activity, which is crucial for their overall health and diabetes management.

Keep in mind

Single-arm study design limits comparison with a control group. Findings may not be generalizable to all young people with Type 1 diabetes. Effectiveness measures were unclear, limiting definitive conclusions.

Published in

Referencia de la Revista

Publication details and source links for this paper.

Vinutha BS, Rachel L, Shaun T, et al. Noninferiority of a Mobile Health App for Exercise Management in Young People with Type 1 Diabetes: A Single-Arm Study. JMIR Diabetes. 2025;10:e68694. doi:10.2196/68694

View DOIView on PubMedView on PMC

Efectos Principales

Rate of level 1 hypoglycemia was 0.79 events per day preapp and 0.83 during app use, indicating no change.

Incidence of level 2 hypoglycemia was similar at 0.25 events per day preapp and 0.24 during app use.

Time spent <3.9 mmol/L was 0.71% preapp and 1.65% during app use, showing no significant difference.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) and Overall perceived quality of the acT1ve app, Percentage of time spent above 10.0 mmol/L, Percentage of time spent with sensor glucose levels <3.9 mmol/L, and 1 more.

This study contributes evidence to

Intervention

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital)

Outcome

Overall perceived quality of the acT1ve app

Evidence topic

Diabetes Technology

Primary intervention

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital)

Primary outcomes

  • Overall perceived quality of the acT1ve app
  • Percentage of time spent above 10.0 mmol/L
  • Percentage of time spent with sensor glucose levels <3.9 mmol/L

Primary intervention

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital)

Primary outcomes

Overall perceived quality of the acT1ve appPercentage of time spent above 10.0 mmol/LPercentage of time spent with sensor glucose levels <3.9 mmol/L

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

4
Evidence pairs
4
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 55

1

Related topics

4

Evidence pairs

156

Related studies

Why it is useful

  • Contributes to 4 evidence relationships
  • Includes primary outcome data
  • Linked to 0 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Agrega evidencia relacionada a tu Evidence Tracker

Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.

Evidencia principal

Tema de evidencia

Diabetes Technology

matched_intervention

Core evidence

Study findings

The primary outcomes reported in this study.

Overall perceived quality of the acT1ve app

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) → Overall perceived quality of the acT1ve app

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) → Overall perceived quality of the acT1ve app

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Percentage of time spent above 10.0 mmol/L

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) → Percentage of time spent above 10.0 mmol/L

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) → Percentage of time spent above 10.0 mmol/L

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Percentage of time spent with sensor glucose levels <3.9 mmol/L

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) → Percentage of time spent with sensor glucose levels <3.9 mmol/L

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) → Percentage of time spent with sensor glucose levels <3.9 mmol/L

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Severe hypoglycemia

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) → Severe hypoglycemia

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) → Severe hypoglycemia

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

La Evidencia Sugiere

  • No significant change in level 1 hypoglycemia rates (0.79 vs 0.83 events/day).
  • Similar level 2 hypoglycemia rates (0.25 vs 0.24 events/day).
  • 80% of participants rated the acT1ve app highly for functionality.
who this applies

A quién se aplica

  • Young individuals aged 12-25 with Type 1 diabetes.
  • Participants managing diabetes through lifestyle interventions.
keep in mind

Tener en Cuenta

  • The study's single-arm design may limit the robustness of the findings.
  • Results may not apply to older populations or those with Type 2 diabetes.
  • The lack of statistical significance in some outcomes suggests cautious interpretation.
between the lines

Entre Líneas

  • Single-arm study design limits comparison with a control group.
  • Findings may not be generalizable to all young people with Type 1 diabetes.
  • Effectiveness measures were unclear, limiting definitive conclusions.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

Desarrollado con el marco Evidence Intelligence™ de Dediabetes

This study contributes to evidence on GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) and Overall perceived quality of the acT1ve app, GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) and Hypoglycemia.

Relaciones de evidencia relacionadas

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Incluido en estas colecciones de evidencia

Curated evidence collections and hubs this study is part of.

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) Evidence Hub

All studies on GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital)

1 studies
intervention_hub

Contributes to GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) evidence base.

Hypoglycemia Evidence Hub

All studies measuring Hypoglycemia

1 studies
outcome_hub

Measures Hypoglycemia as a key outcome.

Overall perceived quality of the acT1ve app Evidence Hub

All studies measuring Overall perceived quality of the acT1ve app

1 studies
outcome_hub

Measures Overall perceived quality of the acT1ve app as a key outcome.

Recent Diabetes Research

Latest published studies

recency_collection

Published within the last 2 years.

Explora más en Evidence Explorer

Jump to pre-filtered views in Evidence Explorer.

All studies on GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) and Overall perceived quality of the acT1ve app

Intervention: GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital)Outcome: Overall perceived quality of the acT1ve app

1 results

All studies on GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) and Severe hypoglycemia

Intervention: GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital)Outcome: Severe hypoglycemia

1 results

All studies on GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital)

Intervention: GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital)

1 results

All studies measuring Overall perceived quality of the acT1ve app

Outcome: Overall perceived quality of the acT1ve app

1 results

All studies measuring Severe hypoglycemia

Outcome: Severe hypoglycemia

1 results

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) improve overall perceived quality of the act1ve app?

Emerging Evidence

GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) appears to improve Overall perceived quality of the acT1ve app.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Overall perceived quality of the acT1ve app

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
View Full Evidence

Does GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) improve percentage of time spent above 10.0 mmol/l?

Emerging Evidence

Current evidence does not show a clear benefit of GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) for Percentage of time spent above 10.0 mmol/L.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Percentage of time spent above 10.0 mmol/L

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
View Full Evidence

Does GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) improve percentage of time spent with sensor glucose levels <3.9 mmol/l?

Emerging Evidence

Current evidence does not show a clear benefit of GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) for Percentage of time spent with sensor glucose levels <3.9 mmol/L.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Percentage of time spent with sensor glucose levels <3.9 mmol/L

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
View Full Evidence

Does GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) affect severe hypoglycemia?

Emerging Evidence

Current evidence does not show a clear benefit of GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) for Severe hypoglycemia.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Severe hypoglycemia

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
View Full Evidence
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Evidence topics

Follow the topics this study contributes to.

Diabetes Technology Evidence Hub

Explore in Evidence Explorer

Open broader Evidence Explorer views for this relationship.

All studies on GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) and Severe hypoglycemiaAll studies on GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) and Overall perceived quality of the acT1ve appAll studies on GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) and Percentage of time spent above 10.0 mmol/LAll studies on GDM-DH mobile app (Garbhakalin Diabetes athawa Madhumeha-Dhulikhel Hospital) and Percentage of time spent with sensor glucose levels <3.9 mmol/L

Related research

Read related research summaries.

Glimepiride increases hypoglycemia risk in type 2 diabetes treatmentAutomated insulin-glucagon delivery reduces hypoglycemia riskEfsitora improves HbA1c control compared to degludec in Japanese adults.Semaglutide improves glycemic control more than insulin aspart in type 2 diabetesSimplified meal announcement maintains glucose control in type 1 diabetes.

Sin anuncios. Sin rastreo.

Centrada en la evidencia, no en la publicidad.

Segura y privada

Tus datos siempre están protegidos.

Siempre al día

Se agregan nuevos estudios todos los días.